Polyunsaturated fatty acid anilides as inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT)
Authors:
- 1 July 1999
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 9 (14) , 2039-2042
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- ACAT-2, A Second Mammalian Acyl-CoA:Cholesterol AcyltransferaseJournal of Biological Chemistry, 1998
- Acyl CoACurrent Opinion in Lipidology, 1998
- Molecular cloning, functional expression and tissue distribution of rat acyl-coenzyme A:cholesterol acyltransferaseBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1998
- The hypolipidemic action of the ACAT inhibitor HL-004 in hamsters fed normal chowGeneral Pharmacology: The Vascular System, 1996
- Tissue-specific Expression and Cholesterol Regulation of Acylcoenzyme A:Cholesterol Acyltransferase (ACAT) in MiceJournal of Biological Chemistry, 1995
- ACAT inhibitors as antiatherosclerotic agents: Compounds and mechanismsMedicinal Research Reviews, 1994
- Inhibitors of Acyl-CoA:Cholesterol Acyltransferase. 1. Synthesis and Hypocholesterolemic Activity of Dibenz[b,e]oxepin-11-carboxanilidesJournal of Medicinal Chemistry, 1994
- Inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT). 2. Modification of fatty acid anilide ACAT inhibitors: bioisosteric replacement of the amide bondJournal of Medicinal Chemistry, 1993
- Inhibitors of acyl-CoA:cholesterol acyltransferase. 1. Identification and structure-activity relationships of a novel series of fatty acid anilide hypocholesterolemic agentsJournal of Medicinal Chemistry, 1992
- Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanismsThe American Journal of Clinical Nutrition, 1990